Efficacy and Safety of Belimumab in Patients With Active Lupus Nephritis
Clinical trial NCT01639339 · COMPLETED
Trial details
- NCT number
- NCT01639339
- Sponsor
- Human Genome Sciences Inc., a GSK Company
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2012-07-12
- Primary completion
- 2019-07-25
- Enrollment
- 448
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.